Industry News
-
RenalytixAI Reaches Milestone of KidneyIntelX Commercial Testing with Mount Sinai Health System
Salt Lake City-based RenalytixAI, today announced the commercial launch of the KidneyIntelX clinical test reporting platform within the…
-
2020 Bench to Bedside Participants Announced
Courtesy of University of Utah Academics & Research Postponed from its original in-person event last April, the annual…
-
BioUtah Member Horizon Therapeutics Named to PEOPLE’s “50 Companies That Care” List
Horizon Therapeutics has been named to PEOPLE’s 2020 “50 Companies That Care” list. Partnering with Great Place to…
-
Bayer Collaborates with Recursion to Strengthen Digital Drug Discovery and Advance New Therapies for Fibrotic Diseases
By Chris Gibson, PhD via Recursion – Drug discovery partnership and equity investment led by Leaps by Bayer…
-
BioUtah and Utah Biotech/Biopharma Companies Raise Concerns About Impact of Trump’s “Most-Favored-Nation” Drug Pricing Order on Innovation
BioUtah, along with 10 Utah biotech and biopharma companies, have sent letters to Utah’s U.S. Senators and Representatives…
-
BioUtah Statement on Launch of Altitude Lab, Largest Life Sciences Incubator in Utah
Recursion and University of Utah found incubator to propel new generation of life sciences in the region August…
-
Recap of Stock Market Update with Monica DiCenso of JP Morgan
After leaving quite an impression to the attendees of the 2020 Entrepreneur and Investor Summit, we brought Monica…
-
Initial Data for Moderna COVID-19 Vaccine Shows Promise
On Tuesday, Moderna announced promising results from the Phase 1 study of its vaccine candidate, called mRNA-1273. The…
-
BioFire Respiratory Panel with COVID Target Scores CE Mark
BioMerieux announced that Utah-based BioFire’s Respiratory Panel 2.1 plus, which tests for SARS-CoV-2 and 23 pathogens encompassing 19…
-
Pfizer, BioNTech Get FDA Fast Track Status for COVID-19 Vaccines
U.S. Pfizer and Germany’s BioNTech announced Monday that they have received Fast Track designation from the FDA for…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- chair
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
